Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

FDA Grants Priority Review for Gene Therapy

A biotechnology company making gene therapies to treat rare diseases says the Food and Drug Administration granted an accelerated review for its treatment of an inherited eye disorder. . . . → Read More: FDA Grants Priority Review for Gene Therapy

Grant Funding Automated Genome Editing System

A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique. . . . → Read More: Grant Funding Automated Genome Editing System

Nanotech Treatment Studied for Brain Tumors

Medical researchers and engineers designed and tested in mice a way to deliver gene-silencing therapies in nanoscale particles to treat glioblastoma, an aggressive form of brain cancer. . . . → Read More: Nanotech Treatment Studied for Brain Tumors

Broad Institute in Crispr Licensing Program

One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology. . . . → Read More: Broad Institute in Crispr Licensing Program

Feasibility, Safety Shown for Personal Tumor Vaccine

A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor. . . . → Read More: Feasibility, Safety Shown for Personal Tumor Vaccine

Glaxo Using Artificial Intelligence for Drug Discovery

Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets. . . . → Read More: Glaxo Using Artificial Intelligence for Drug Discovery

Second Trial Approved for Cancer Pain Drug

The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer. . . . → Read More: Second Trial Approved for Cancer Pain Drug

Simple, Inexpensive Pathogen Detector Developed

A simple and inexpensive detection device is being created to find disease-causing microbes in samples of food, water, and human specimens. . . . → Read More: Simple, Inexpensive Pathogen Detector Developed

Preclinical Data Show Promise for Diabetic Eye Drug

Early evidence shows a drug designed as eye drops to treat diabetic macular edema, an eye disease in people with diabetes, permeates the entire eye, including the retina. . . . → Read More: Preclinical Data Show Promise for Diabetic Eye Drug

Computer-Designed Antibodies Target Alzheimer’s Proteins

Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease. . . . → Read More: Computer-Designed Antibodies Target Alzheimer’s Proteins